Search research articles
Contact Us
Filters
Showing results (11-20 of 39) with videos related to
Page
of 4
Sort By:
Therapeutic Drug Monitoring
|
January 1, 1985
Influence of body fat on the volume of distribution of theophylline
P J Jewesson, R J Ensom
Clinical Therapeutics
|
January 1, 1994
Amphotericin B use in a major acute care hospital
T Nicholl, P Phillips, P J Jewesson
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 5, 1997
Tracking and reporting drug expenditures
L Frighetto, C A Marra, P J Jewesson
Antimicrobial Agents and Chemotherapy
|
October 1, 1989
Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin
W R Bowie, V Willetts, P J Jewesson
Hospital Formulary
|
December 10, 1988
Impact of a two-stage intervention program on cefazolin usage at a major teaching hospital
S Gupta, R L Bachand, P J Jewesson
Drug Intelligence & Clinical Pharmacy
|
September 1, 1988
Unique two-stage intervention to modify prescribing trends
S Gupta, R L Bachand, P J Jewesson
DICP : the Annals of Pharmacotherapy
|
May 1, 1990
Simple ways to promote cost containment
D M Bunz, L Frighetto, S Gupta, et al.
The Canadian Journal of Hospital Pharmacy
|
February 1, 1995
Ciprofloxacin use under a reserved drug and stepdown promotion program
L Frighetto, S M Martinusen, F Mamdani, et al.
The Journal of Infectious Diseases
|
November 1, 1988
Kinetics of intraventricular vancomycin in infections of cerebrospinal fluid shunts
C Reesor, A W Chow, A Kureishi, et al.
European Journal of Haematology. Supplementum
|
January 1, 1993
Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients
A W Chow, P J Jewesson, A Kureishi, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 39) with videos related to
Sort By:
Page
of 4
Therapeutic Drug Monitoring
|
January 1, 1985
Influence of body fat on the volume of distribution of theophylline
P J Jewesson, R J Ensom
Clinical Therapeutics
|
January 1, 1994
Amphotericin B use in a major acute care hospital
T Nicholl, P Phillips, P J Jewesson
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 5, 1997
Tracking and reporting drug expenditures
L Frighetto, C A Marra, P J Jewesson
Antimicrobial Agents and Chemotherapy
|
October 1, 1989
Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin
W R Bowie, V Willetts, P J Jewesson
Hospital Formulary
|
December 10, 1988
Impact of a two-stage intervention program on cefazolin usage at a major teaching hospital
S Gupta, R L Bachand, P J Jewesson
Drug Intelligence & Clinical Pharmacy
|
September 1, 1988
Unique two-stage intervention to modify prescribing trends
S Gupta, R L Bachand, P J Jewesson
DICP : the Annals of Pharmacotherapy
|
May 1, 1990
Simple ways to promote cost containment
D M Bunz, L Frighetto, S Gupta, et al.
The Canadian Journal of Hospital Pharmacy
|
February 1, 1995
Ciprofloxacin use under a reserved drug and stepdown promotion program
L Frighetto, S M Martinusen, F Mamdani, et al.
The Journal of Infectious Diseases
|
November 1, 1988
Kinetics of intraventricular vancomycin in infections of cerebrospinal fluid shunts
C Reesor, A W Chow, A Kureishi, et al.
European Journal of Haematology. Supplementum
|
January 1, 1993
Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients
A W Chow, P J Jewesson, A Kureishi, et al.
Page
of 4